These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38292061)

  • 61. The role of the transcription factor SIM2 in prostate cancer.
    Lu B; Asara JM; Sanda MG; Arredouani MS
    PLoS One; 2011; 6(12):e28837. PubMed ID: 22174909
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic evaluation of the novel blueprint of DNA methylation sites by integrating bulk RNA-sequencing and methylation modification data in endometrial cancer.
    Zhou H; Zhang Y; Jin J; Shen K; Yang Y; Lao P
    J Gene Med; 2024 Jan; 26(1):e3638. PubMed ID: 38011892
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A 13-Gene Signature Based on Estrogen Response Pathway for Predicting Survival and Immune Responses of Patients With UCEC.
    Li Y; Tian R; Liu J; Ou C; Wu Q; Fu X
    Front Mol Biosci; 2022; 9():833910. PubMed ID: 35558564
    [No Abstract]   [Full Text] [Related]  

  • 65. Gene Signatures and Prognostic Value of m6A RNA Methylation Regulators in Uterine Corpus Endometrial Carcinoma.
    Feng Y; Yao C; Shen J; Zhou J
    Discov Med; 2021; 31(164):111-120. PubMed ID: 35188885
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Discovery of therapeutic targets of quercetin for endometrial carcinoma patients infected with COVID-19 through network pharmacology.
    Li K; Liu H; Lin Y; Gu L; Xiang X; Zhu X
    Front Oncol; 2023; 13():1151434. PubMed ID: 36969077
    [TBL] [Abstract][Full Text] [Related]  

  • 67. miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.
    Lu X; Jing L; Liu S; Wang H; Chen B
    Int J Endocrinol; 2022; 2022():5006123. PubMed ID: 35719192
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A 14-Methylation-Driven Differentially Expressed RNA as a Signature for Overall Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
    Zeng Z; Cheng J; Ye Q; Zhang Y; Shen X; Cai J; Li M
    DNA Cell Biol; 2020 Jun; 39(6):975-991. PubMed ID: 32397815
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Integrative analysis reveals methylenetetrahydrofolate dehydrogenase 1-like as an independent shared diagnostic and prognostic biomarker in five different human cancers.
    Sial N; Rehman JU; Saeed S; Ahmad M; Hameed Y; Atif M; Rehman A; Asif R; Ahmed H; Hussain MS; Khan MR; Ambreen A; Ambreen A
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34908119
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma.
    Cai X; Zhou J; Deng J; Chen Z
    Cancer Cell Int; 2021 Dec; 21(1):701. PubMed ID: 34937564
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MCM10: An effective treatment target and a prognostic biomarker in patients with uterine corpus endometrial carcinoma.
    Chen J; Wu S; Wang J; Han C; Zhao L; He K; Jia Y; Cui M
    J Cell Mol Med; 2023 Jun; 27(12):1708-1724. PubMed ID: 37246638
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hypomethylated gene RAC3 induces cell proliferation and invasion by increasing FASN expression in endometrial cancer.
    Meijuan C; Fang L; Min F; Qian W
    Int J Biochem Cell Biol; 2022 Sep; 150():106274. PubMed ID: 35917927
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma.
    Gu H; Song J; Chen Y; Wang Y; Tan X; Zhao H
    Front Oncol; 2022; 12():923641. PubMed ID: 35719911
    [TBL] [Abstract][Full Text] [Related]  

  • 74. TPD52 as a Potential Prognostic Biomarker and its Correlation with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma: Bioinformatic Analysis and Experimental Verification.
    Miao L; Chen B; Jing L; Zeng T; Chen Y
    Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38305309
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis.
    Zheng X; Chen L; Liu W; Zhao S; Yan Y; Zhao J; Tian W; Wang Y
    Hereditas; 2023 Mar; 160(1):13. PubMed ID: 36964635
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma.
    Zhang F; Wang Y; Li H; Li L; Yang X; You X; Tang L
    Front Oncol; 2023; 13():1118906. PubMed ID: 36925915
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinicopathological role of Cyclin A2 in uterine corpus endometrial carcinoma: Integration of tissue microarrays and ScRNA-Seq.
    Mo WJ; Liang ZQ; Huang JZ; Huang ZG; Zhi ZF; Chen JH; Chen G; Zeng JJ; Feng ZB
    Int J Biol Markers; 2024 Jun; 39(2):168-183. PubMed ID: 38646803
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Circadian Gene NPAS2 Act as a Putative Tumor Stimulative Factor for Uterine Corpus Endometrial Carcinoma.
    Zheng X; Lv X; Zhu L; Xu K; Shi C; Cui L; Ding H
    Cancer Manag Res; 2021; 13():9329-9343. PubMed ID: 34992456
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long non‑coding RNA CASC15 facilitates esophageal squamous cell carcinoma tumorigenesis via decreasing SIM2 stability via FTO‑mediated demethylation.
    Qin B; Dong M; Wang Z; Wan J; Xie Y; Jiao Y; Yan D
    Oncol Rep; 2021 Mar; 45(3):1059-1071. PubMed ID: 33650646
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of an Immune-Related LncRNA Prognostic Signature in Uterine Corpus Endometrial Carcinoma Patients.
    Sun XX; Wen HQ; Zhan BX; Yang P
    Clin Lab; 2021 Nov; 67(11):. PubMed ID: 34758230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.